Cardiovascular events during treatment with anti-BCMA chimeric antigen receptor T-cells in multiple myeloma

被引：0
|
作者：
Mathilde, Chanut
机构：
来源：
HEMATOLOGIE | 2023年 / 29卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：274 / 275
页数：2
相关论文
共 50 条
  • [1] CARDIAC EVENTS AFTER ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T-CELL (IDECABTAGENE VICLEUCEL) FOR MULTIPLE MYELOMA
    Lee, Dae Hyun
    Chandrasekhar, Sanjay Amrith
    Jain, Michael
    Hansen, Doris
    Freeman, Ciara
    Alsina, Melissa
    Baz, Rachid
    Puglianini, Omar Castaneda
    Liu, Hien
    Blue, Brandon
    Davila, Marco L.
    Faramand, Rawan
    Kumar, Abhishek
    Shah, Bijal
    Lazaryan, Aleksandr
    Khimani, Farhad
    Nishihori, Taiga
    Bachmeier, Christina
    Locke, Frederick
    Oliveira, Guilherme Henrique
    Alomar, Mohammed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1933 - 1933
  • [2] Lenalidomide Enhances Anti-BCMA Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma
    Works, Melissa
    Soni, Neha
    Hauskins, Collin
    Sierra, Catherine
    Baturevych, Alex
    Jones, Jon
    Curtis, Wendy
    Johnstone, Timothy
    Kugler, David
    Jiang, Yue
    Hause, Ron
    Sather, Blythe Duke
    Salmon, Ruth
    Ports, Michael
    BLOOD, 2017, 130
  • [3] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
  • [4] HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma
    Lebel, Eyal
    Asherie, Nathalie
    Kfir-Erenfeld, Shlomit
    Grisariu, Sigal
    Avni, Batia
    Elias, Shlomo
    Assayag, Miri
    Dubnikov-Sharon, Tali
    Zimran, Eran
    Shaulov, Adir
    Pick, Marjorie
    Cohen, Cyrille
    Stepensky, Polina
    Gatt, Moshe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S22 - S22
  • [5] PHASE I, OPEN-LABEL TRIAL OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Zhang, W.
    Zhao, W.
    Liu, J.
    He, A.
    Chen, Y.
    Cao, X.
    Yang, N.
    Wang, B.
    Zhang, P.
    Zhang, Y.
    Wang, F.
    Lei, B.
    Gu, L.
    Yang, Y.
    Bai, J.
    Zhang, R.
    Wang, X.
    Ma, X.
    Wang, J.
    Wang, J.
    Wei, L.
    Zhang, J.
    Zang, X.
    Zhuang, Q.
    Fan, F. X.
    HAEMATOLOGICA, 2017, 102 : 2 - 3
  • [6] Allogeneic chimeric antigen receptor T-cells and multiple myeloma
    Malard, Florent
    HEMATOLOGIE, 2021, 27 : 13 - 18
  • [7] Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Zhang, Lina
    Shen, Xuxing
    Yu, Wenjun
    Li, Jing
    Zhang, Jue
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    ANNALS OF MEDICINE, 2021, 53 (01) : 1547 - 1559
  • [8] Chimeric Antigen Receptor T Cells for the Treatment of Multiple Myeloma
    Testa, Ugo
    Pelosi, Elvira
    Castelli, Germana
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [9] Anti-BCMA chimeric antigen receptor T-cell therapy in multiple myeloma: despite a strong efficacy, persistence of autologous T cells remains a major challenge
    Karlin, Lionel
    HEMATOLOGIE, 2021, 27 : 5 - 12
  • [10] Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma
    Hasanali, Zainul S.
    Razzo, Beatrice
    Susanibar-Adaniya, Sandra P.
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    Cohen, Adam D.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 383 - 406
12345